166 related articles for article (PubMed ID: 30635657)
1. Non-canonical BAD activity regulates breast cancer cell and tumor growth via 14-3-3 binding and mitochondrial metabolism.
Mann J; Githaka JM; Buckland TW; Yang N; Montpetit R; Patel N; Li L; Baksh S; Godbout R; Lemieux H; Goping IS
Oncogene; 2019 May; 38(18):3325-3339. PubMed ID: 30635657
[TBL] [Abstract][Full Text] [Related]
2. Bad expression predicts outcome in patients treated with tamoxifen.
Cannings E; Kirkegaard T; Tovey SM; Dunne B; Cooke TG; Bartlett JM
Breast Cancer Res Treat; 2007 Apr; 102(2):173-9. PubMed ID: 17004114
[TBL] [Abstract][Full Text] [Related]
3. Bag-1 stimulates Bad phosphorylation through activation of Akt and Raf kinases to mediate cell survival in breast cancer.
Kizilboga T; Baskale EA; Yildiz J; Akcay IM; Zemheri E; Can ND; Ozden C; Demir S; Ezberci F; Dinler-Doganay G
BMC Cancer; 2019 Dec; 19(1):1254. PubMed ID: 31883527
[TBL] [Abstract][Full Text] [Related]
4. Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury.
Wang XT; Pei DS; Xu J; Guan QH; Sun YF; Liu XM; Zhang GY
Cell Signal; 2007 Sep; 19(9):1844-56. PubMed ID: 17555943
[TBL] [Abstract][Full Text] [Related]
5. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
[TBL] [Abstract][Full Text] [Related]
6. Α-eleostearic acid inhibits growth and induces apoptosis in breast cancer cells via HER2/HER3 signaling.
Zhuo RJ; Wang F; Zhang XH; Zhang JJ; Xu J; Dong W; Zou ZQ
Mol Med Rep; 2014 Mar; 9(3):993-8. PubMed ID: 24425042
[TBL] [Abstract][Full Text] [Related]
7. Myricetin inhibits Akt survival signaling and induces Bad-mediated apoptosis in a low dose ultraviolet (UV)-B-irradiated HaCaT human immortalized keratinocytes.
Kim W; Yang HJ; Youn H; Yun YJ; Seong KM; Youn B
J Radiat Res; 2010; 51(3):285-96. PubMed ID: 20339252
[TBL] [Abstract][Full Text] [Related]
8. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
[TBL] [Abstract][Full Text] [Related]
9. PTH inactivates the AKT survival pathway in the colonic cell line Caco-2.
Calvo N; de Boland AR; Gentili C
Biochim Biophys Acta; 2010 Mar; 1803(3):343-51. PubMed ID: 20005908
[TBL] [Abstract][Full Text] [Related]
10. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
Wu JS; Lin TN; Wu KK
J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
[TBL] [Abstract][Full Text] [Related]
12. Akt/Bad signaling and motor neuron survival after spinal cord injury.
Yu F; Sugawara T; Maier CM; Hsieh LB; Chan PH
Neurobiol Dis; 2005 Nov; 20(2):491-9. PubMed ID: 15896972
[TBL] [Abstract][Full Text] [Related]
13. JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3.
Sunayama J; Tsuruta F; Masuyama N; Gotoh Y
J Cell Biol; 2005 Jul; 170(2):295-304. PubMed ID: 16009721
[TBL] [Abstract][Full Text] [Related]
14. Survival-factor-induced phosphorylation of Bad results in its dissociation from Bcl-x(L) but not Bcl-2.
Hirai I; Wang HG
Biochem J; 2001 Oct; 359(Pt 2):345-52. PubMed ID: 11583580
[TBL] [Abstract][Full Text] [Related]
15. AKT delays the early-activated apoptotic pathway in UVB-irradiated keratinocytes via BAD translocation.
Claerhout S; Decraene D; Van Laethem A; Van Kelst S; Agostinis P; Garmyn M
J Invest Dermatol; 2007 Feb; 127(2):429-38. PubMed ID: 16932738
[TBL] [Abstract][Full Text] [Related]
16. The Bcl-2-associated death promoter (BAD) lowers the threshold at which the Bcl-2-interacting domain death agonist (BID) triggers mitochondria disintegration.
Howells CC; Baumann WT; Samuels DC; Finkielstein CV
J Theor Biol; 2011 Feb; 271(1):114-23. PubMed ID: 21130780
[TBL] [Abstract][Full Text] [Related]
17. Melatonin prevents nitric oxide-induced apoptosis by increasing the interaction between 14-3-3beta and p-Bad in SK-N-MC cells.
Choi SI; Joo SS; Yoo YM
J Pineal Res; 2008 Jan; 44(1):95-100. PubMed ID: 18078454
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer.
Al-Bazz YO; Underwood JC; Brown BL; Dobson PR
Eur J Cancer; 2009 Mar; 45(4):694-704. PubMed ID: 19138840
[TBL] [Abstract][Full Text] [Related]
19. Dihydromyricetin induces mitochondria-mediated apoptosis in HepG2 cells through down-regulation of the Akt/Bad pathway.
Zhang Z; Zhang H; Chen S; Xu Y; Yao A; Liao Q; Han L; Zou Z; Zhang X
Nutr Res; 2017 Feb; 38():27-33. PubMed ID: 28381351
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PI3-kinase-Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell line.
Nuutinen U; Postila V; Mättö M; Eeva J; Ropponen A; Eray M; Riikonen P; Pelkonen J
Exp Cell Res; 2006 Feb; 312(3):322-30. PubMed ID: 16309671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
